We explored socioeconomic and demographic disparities in breast cancer (BC) stage at presentation and survival in a Swiss population-based sample of female BC patients linked to the census-based Swiss National Cohort. Tumor stage was classified according to Surveillance, Epidemiology and End Results Program summary stage (in situ/localized/regional/distant). We used highest education level attained to estimate SEP (low/middle/high). Further demographic characteristics of interest were age at presentation (30-49/50-69/70-84 years), living in a canton with organized screening (yes/no), urbanity of residence (urban/ peri-urban/rural), civil status (single/married/widowed/divorced) and nationality (Swiss/non-Swiss). We used ordered logistic regression models to analyze factors associated with BC stage at presentation and competing risk regression models for factors associated with survival. Odds of later-stage BC were significantly increased for low SEP women (odds ratio 1.19, 95%CI 1.06-1.34) compared to women of high SEP. Further, women living in a canton without organized screening program, women diagnosed outside the targeted screening age and single/widowed/divorced women were more often diagnosed at later stages. Women of low SEP experienced an increased risk of dying from BC (sub-hazard ratio 1.22, 95%CI 1.05-1.43) compared to women of high SEP. Notably, these survival inequalities could not be explained by socioeconomic differences in stage at presentation and/or other sociodemographic factors. It is concerning that these social gradients have been observed in a country with universal health insurance coverage, high health expenditures and one of the highest life expectancies in the world. 
Several studies outside of Switzerland have reported negative associations between socioeconomic position (SEP) and BC stage at presentation as well as socioeconomic inequalities in survival after BC diagnosis. 3 Socioeconomic and demographic factors may influence access to health care, 4 cancer awareness 5 and woman's attitudes toward preventive methods such as mammography screening, clinical breast examination and breast self-examination. 6 In Switzerland, health care is organized at the cantonal level, resulting in regional differences in provision of cancer prevention and management services. 7 A Swiss BC pattern of care study, for example, reported considerable regional variations in early BC detection and treatment. 7 In western Switzerland (French-speaking part of the country), organized BC screening programs have gradually been implemented since 1999 for women aged 50-69 years, whereas in most other regions (German and Italian-speaking parts of Switzerland) only opportunistic screening is available. 8 Consequently, screening uptake varies by canton and region. The Swiss Health Survey 2012 reports that in 2010-2011, cantons with organized mammography screening had a 68% mammogram coverage of women in the recommended screening age (50-69 years), compared to 37% in cantons without an organized program. 9 Organized BC screening may reduce social inequalities in screening uptake, 10, 11 although this has not been consistently observed across countries. 12 Several studies have identified stage at presentation as an important factor in survival differences between socioeconomic groups. 13 In most studies, however, disparities remained after adjustment for stage and other tumor and demographic characteristics. 13 Remaining disparities have been associated with treatment disparities, variations in comorbidities and/or additional factors like variations in psychosocial well-being and patients' support. 13 In Geneva, women with lower SEP were diagnosed with more advanced BC, received more often suboptimal treatment and showed lower cause-specific and overall survival.
14 A later study in Geneva, observed substantial social inequalities in BC management including diagnostic procedures and primary treatment. 15 A major goal of health care systems is to equally improve the health in all groups of the population they serve. 16 Despite this aim, socioeconomic and -demographic health inequalities in BC detection and survival have been observed all over the world, 13 including countries with tax-funded health care systems designed to provide equal access to care. 17, 18 Swiss data on socioeconomic health inequalities in stage at presentation and survival of BC in women is very limited. Therefore, this study aimed to evaluate socioeconomic and demographic disparities in BC stage at presentation and survival in a Swiss population-based sample of female BC patients diagnosed between 2001 and 2008.
Material and Methods

Data sources and inclusion criteria
This study is based on data from the SNC-NICER Cancer Epidemiology Study. The SNC-NICER Cancer Epidemiology Study took advantage of the Swiss National Cohort (SNC) and the National Institute for Cancer Epidemiology and Registration (NICER) cancer registry (CR) network to build a comprehensive historical cohort, allowing epidemiologic analysis of factors associated with cancer incidence, mortality and survival in Switzerland.
A detailed description of the SNC can be found elsewhere. 19 Briefly, 1990 and 2000 census records were probabilistically linked to cause-specific mortality or emigration records from 1991-2013 provided by the Federal Statistical Office (FSO). The Swiss census is mandatory and virtually complete with a 2000 census estimated coverage of 98.6%. 19 This study used SNC sociodemographic information on sex, education level, marital status, place of residence and nationality at census date. The coding of the underlying cause of death is federally standardized by the FSO. Since 1995, the 10th revision of the international classification of diseases and related health problems (ICD-10) has been used following international standards.
In Switzerland, cancer registration is primarily organized at the cantonal level. The earliest CR data is available from Geneva dating back to 1970, followed by Vaud and Neuchâtel (1974) Stage at presentation analyzes were based on data from a subset of cantonal cancer registries (Geneva, Valais, Zurich) that provided breast carcinoma in situ cases (N 5 10,915). In a supplemental analysis, stage at presentation calculations were repeated and limited to invasive BCs to enable the inclusion of all participating cancer registries (Supporting Information Table S1 ). The supplemental analysis followed survival analyzes were based on invasive cancers including all participating cancer registries (16, 296) .
Analytic methods
Surveillance, Epidemiology and End Results (SEER) Program summary stage was calculated based on the TNM classification system following the algorithm for mapping stage at diagnosis from TNM to SEER summary stage as described by Walters et al. 20 We used SEER summary stage instead of the more detailed TNM staging system due to extensive and significant revision in BC staging between the fifth and sixth TNM edition.
We prioritized pathological T and N over clinical T and N. Missing M or Mx were assumed to be equivalent to M0. For women within the recommended screening age, we conducted a sub-analysis of Valais and Geneva, the only two cantons which both, offered organized screening during the study period and provided carcinoma in situ cases to the study population. We examined the association between being diagnosed within or outside the organized program and SEP using logistic regression including civil status and nationality and canton of residence as covariates.
Survival was analyzed using competing risk regressions based on Fine and Gray's proportional hazard model. 21 All underlying causes of death other than BC were classified as competing risks. Four models have been calculated using the following variables as predictors: (model 1) SEP; (model 2) model 1 plus age at presentation, civil status and nationality; (model 3) model 2 plus stage at presentation; and (model 4) model 3 plus urbanity of residence and canton with or without organized screening program. Results of survival analyzes are reported as sub-hazard ratios of death due to BC (SHRs) with 95% confidence intervals (95%CI).
Both final models (stage at presentation and survival analyzes) have been additionally adjusted for canton of residence to account for unmeasured canton characteristics associated with SEP distribution and stage at diagnosis/survival.
All analyzes were performed using the statistical software package Stata, version 13.1 for Windows (StataCorp, College Station, TX).
Results
Patient characteristics by SEP cases included in stage at presentation and survival analyzes are listed in Table 1 . Incident breast carcinoma cases (N total 5 10,915, N staged 5 10,362) by CR
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Feller et al. We observed higher proportions of early stage BC (carcinoma in situ and localized cancers) in cantons with organized BC screening compared to the canton without organized screening (Fig. 1 ). In the recommended screening age-Group (50-69 years), the observed proportion of early stage BC (carcinoma in situ and localized BC) was 64.7 vs. 51.9% (low SEP), 65.0 vs. 57.0% (middle SEP) and 69.4 vs.
56.6% (high SEP)
. A similar tendency toward higher proportions of early stage BC in cantons with organized screening (regardless of SEP) was also observed in the age-Group 70-84 years. However, due to comparably high number of cases without stage information, i.e., in the canton without organized screening, figures for this age-group are difficult to interpret. In women aged 30-49 years, early stage detection in women varied across SEPs between 56.9% (middle SEP) and 59.5% (high SEP) in cantons with organized screening and 50.0% (middle SEP) and 53.3% (high SEP) in the canton without organized screening.
When looking at carcinoma in situ cases in women in the recommended screening age-group, only women living in a canton with organized screening program showed a social gradient with 9.3, 11.9 and 15.0% of carcinoma in situ cases for low, middle and high SEP women, respectively. In the canton without organized screening, the proportion of carcinoma in situ cases were fairly stable with 8.5% (low SEP), 9.8% (middle SEP) and 8.2% (high SEP).In cantons with organized programs, 16% (canton Geneva) and 32% (canton Valais) of diagnosed BC cases in the age-group eligible for organized BC screening were detected within the framework of an organized program. Compared to women with high SEP, women with middle (OR 1.25, 95%CI 1.03-1.53) and low SEP (OR 1.39, 95%CI 1.11-1.73) were more likely to be diagnosed outside of the organized screening program.
BC survival
Stage information was lacking in 5.1% (Table 1) . Of the 16,296 incident cases included in the survival analyzes, 3,713 
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cases died before the end of follow-up (22.8%) and 229 (1.4%) were lost-to-follow-up. In all models, diagnosed women with low SEP were more likely to die of BC compared to women with high SEP ( Further, living in a non-urban region was associated with an increased risk of BC death with SHRs of 1.13 (95%CI 1.02-1.26; peri-urban region) and 1.21 (95%CI 1.03-1.41; rural region). Residents of foreign nationality were at lower risk of dying from their BC (SHR 0.84, 95%CI 0.73-0.98). We observed no statistically significant effects for civil status in the fully adjusted model (Table 3) .
Discussion
Summary of main findings
Despite universal health insurance coverage, 22 high health expenditures, 22 the highest average household net financial wealth worldwide 23 and one of the highest life expectancies in the world, 24 high risk groups for later-stage BC and lower BC survival were identified in Switzerland. In our study, women of lower SEP, unmarried women, women below (<50 years) or above (>69 years) the recommended screening age and women living in a canton with no organized BC screening program showed an increased risk of being diagnosed with a later-stage BC. In addition, women of lower SEP experienced poorer disease-specific survival. Notably, these survival inequalities could not be explained by socioeconomic differences in stage at presentation and/or other sociodemographic factors such as age, nationality and civil status.
Discussion in the context of the literature
Our Swiss results are in line with international data, showing that lower SEP is associated with later-stage BC and shortened survival. 3 Much of the deprivation gap in survival can be attributed to inequalities in stage at presentation, the most important single predictor for BC survival. 13, 25 However, in most research socioeconomic survival gaps remained in stage-stratified analyzes or after adjustment for stage at diagnosis. 13, 25 Further, socioeconomic inequalities for BC stage and survival were observed in various countries irrespective of the measurement used for SEP classification (e.g., education, occupation, income, area-based deprivation index). 13 Possible reasons for the delayed BC diagnosis in lower SEP women might be related to inequalities in health care access, 4 cancer awareness 5 and/or attitudes towards cancer (e.g., cancer fatalism). 6 All these factors might substantially contribute to observed disparities in BC screening uptake, 11, 26 and/or cancer-related health behavior such as health care seeking after detection of first symptoms (patient-mediated delay). 27 Essentially, equal access to health care goes beyond universal health insurance coverage and adequate provision of accessible health services (such as provision in proximity of the patient's residence). 28 Additional factors such as language barriers, uncovered costs (travel costs, childcare during consultation/treatment) or previous negative health care experiences might hamper health care access of individuals and specific social groups. 29 Disparities in cancer awareness might have also influenced the results. In a Danish study, for example, lower SEP was associated with less awareness of BC symptoms and risk factors. 5 Further, fatalistic attitudes towards cancer have been shown to be associated with lower SEP, 6, 30 whereas cancer fatalism in turn was associated with being less positive about early detection and being more fearful about seeking help for suspicious symptoms. 30 In our study, we observed a social shift towards higher proportions of carcinoma in situ cases for women in the recommended screening age only in cantons offering organized screening. In the canton without organized screening, proportions of carcinoma in situ cases were fairly equal across SEP groups, similar to those observed in low SEP women in cantons with organized screening. As carcinoma in situ are rare in the symptomatic setting, observed variations were most likely caused by differences in mammography screening use (organized and/or opportunistic). In the canton without organized screening program, social inequalities in early detection were mainly visible for localized BC indicating that in this canton other factors such as inequalities in cancer awareness/knowledge, health care access and/or help seeking behavior after detection of symptoms might have led to the observed results.
In our study, socioeconomic inequalities in survival remained after adjusting for stage at presentation suggesting that further factors such as treatment disparities and/ or variations in comorbidities might play a role. This assumption is supported by the findings in the canton of Geneva, where lower SEP women were more likely to receive suboptimal treatment compared to their more affluent counterparts. 14, 15 In women aged 70-84 years, lower SEP was associated with an increased proportion of unstaged BCs. However, a clear social gradient was only apparent in the cantons with organized screening programs. Women 85 years and older were excluded from the analyzes because of the high proportion with missing stage information despite the fact that tumor stage should be investigated (at least clinically) in all women with BC. 31 However, a distinction must be made between a true lack of stage information and a lack of reporting stage. 32 A true lack of staging might occur in patients Survival was analyzed using competing risk regressions based on Fine and Gray's proportional hazard model. 21 All underlying causes of death other than BC were classified as competing risks. Four models have been calculated using the following variables as predictors: (model 1) SEP; (model 2) model 1 plus age at presentation, civil status and nationality; (model 3) model 2 plus stage at presentation; and (model 4) model 3 plus canton with or without organized screening program and urbanity of residence. The fourth model has been additionally adjusted for canton of residence. Results are reported as sub-hazard ratios for BC survival (SHRs) with 95% confidence intervals (95%CI). with very limited life expectancy (severe comorbidities, high age) 32, 33 or due to patients' choice. 32, 34 In contrast, lack of reporting refers to cases where clinical and/or pathological stage has been investigated but has not been captured by the CR. A study investigating the completeness of BC staging in the New Zealand CR, found that 12% of staged BC cases were recorded as unknown stage in the CR system. 32 Although observed socioeconomic inequalities in diagnostic assessment might be-at least partly-explained by the fact that comorbidities are more common in lower SEP women and in older women. 35 Biennial mammography coverage in the recommended screening age was substantially higher in cantons with an organized program (located in the western, French-speaking region of Switzerland) compared to cantons without organized program. 9 However, the participation rate in the organized programs varied substantially across cantons. In 2004, screening coverage in the organized program of women aged 50-69 years was 23% in Geneva compared to 66% in Valais. 36 Importantly, opportunistic screening has widely been offered concomitantly to organized programs in Switzerland. 36 A prospective study in Geneva reported that only 12% of women invited to screening were screened within the organized program and 39% received screening outside of the framework of the organized program. 10 Therefore, the lower participation rate in the Geneva program likely reflects a higher prevalence of opportunistic screening rather than real differences in mammography coverage. 37 In our analyzes, the cantons with organized BC screening programs showed a shift toward earlier stages in women aged 50 years and older compared to the canton without an implemented program. A similar shift-albeit less pronounced-has been observed for younger women below the recommended screening age indicating that younger women in cantons with organized screening are more likely to undergo mammography screening than their counterparts in cantons without a program.
Women outside the recommended screening age showed an increased risk of being diagnosed at later stages. For the time period under investigation, the recommended screening age in Switzerland was 50-69 years. The age-cut was based on the fact that at this time the most convincing evidence for a beneficial effect available from randomized controlled trials existed for women aged 50-69 years. However, women older than 69 years were allowed to continue screening within the organized program if desired and if no major comorbidities existed. 36 Diagnosing BC by mammography is more difficult in younger women because their breast tissue is denser making it hard to detect anomalies-the main reason why mammography screening is not recommended for younger women. 36 BC in younger women has been shown to be more aggressive 38 and have a less favorable prognosis, 39 although the latter has not been consistently observed. 40 In our study, we observed an increased survival for women below the age of 50 years compared to their older counterparts (overall and adjusted for stage at presentation). An earlier Swiss study found that women with BC diagnosed below the age of 40 years had substantially lower survival than women diagnosed between the age of 40-49 years. 39 Due to the small number of cases below the age of 40 years we categorized younger women as < 50 years thus potential survival disadvantages in the very young women could not be examined in this study.
Several studies outside of Switzerland observed beneficial impacts of being married in regard to BC stage at presentation and survival after BC, 13, 41 indicating that social support might have a significant impact on cancer detection, treatment and survival. 41 A study in the United States observed that unmarried women were at higher risk of being diagnosed with metastatic cancer, under-treatment and death resulting from their cancer. 41 In our study, we observed an increased risk for unmarried women for being diagnosed with later stage BC (albeit not reaching significance for widowed women). For survival after BC, we observed a significantly lower survival only in single women and only if not adjusted for stage at diagnosis. In this study, marital status was obtained from the census and with increasing time between date of census and end of follow-up, marital status might have changed leading to misclassification when referring to the time of or after diagnosis.
In our study, women living in non-urban regions showed lower survival compared to their urban counterparts. Factors that may mediate these disparities may include inequalities in tumor characteristics (i.e., stage at presentation), patients' treatment preferences and adherence and/or access to and quality of care received. However, in our study we did not observe significant disparities in stage at presentation between the rural and urban population suggesting that differences in early detection played a minor role.
Compared to women with Swiss nationality, our results suggest that women of foreign nationality have an overall and stage-specific survival benefit. A potential explanation for these differences is the so-called "healthy migrant effect." The healthy migrant effect describes an empirically observed mortality advantage of migrants relative to the population in the host country due to self-selection of migrants who tend to differ from their fellow countrymen in respect to education, risk exposure or health, leading to better health outcomes despite potential social inequalities and discrimination in the host country. However, data quality issues might have affected the results in this study. Death records of non-Swiss residents showed an increased probability of not being linked to census data compared to death records of Swiss nationals 19 and (undocumented) out-migration may have led to incomplete mortality follow-up, especially in semi-skilled or unskilled migrant workers, who tend to leave the home country when they are sick or disabled. 42 Additionally, it is difficult to draw conclusions for the non-Swiss population because it is a highly heterogeneous group. Non-Swiss have different countries of origin, migration status (first, second or third generation immigrants), type of residence permit, level of education,
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employment and income, to name a few. Hence, this topic should be investigated further in future studies.
Strengths and Limitations
This is the first Swiss study investigating socioeconomic inequalities of BC stage at presentation and survival, combining data from multiple Swiss cantons and from a national census. Overall, the study population had <0.5% DCO cases indicating a high completeness of case ascertainment. In the age-group under investigation, stage information was available for 95% of all cases.
Our study has some limitations. First, the meaning and consequences of educational attainment might vary by birth cohort. 43 However, there is considerable international evidence that education is strongly associated with health, health behavior and preventive service use and that a substantial share of these effects are of causal origin. 44 In addition, individual education is generally stable beyond early adulthood whereas civil status and living conditions are more likely to change over time and individual education level was virtually complete (>99%) in the study population. In a preceding analysis, we compared three indicators of SEP in relation to stage at presentation: (i) education woman-highest education level attained by the woman (compulsory or less, upper-secondary, upper-tertiary education), (ii) education couple-if married, highest education level attained by the woman or spouse and (iii) quintiles of the Swiss neighborhood index (Swiss-SEP), a composite area-level SEP measure based on income, education, occupation and housing conditions. 45 Regardless of SEP indicator used, we observed comparable patterns and effects for SEP and the covariates included in the models, 46 although importantly, each indicator of SEP measures different aspects of socioeconomic stratification. 43 Overall, only 7 out of 26 Swiss cantons participated in the study covering around 46% of the population. Further, stage at presentation analyzes were restricted to cantonal cancer registries providing carcinoma in situ cases diminishing population coverage for these analyzes to 27%. The resulting study sample was not representative for the female Swiss population with respect to SEP, urbanity or residence and nationality. Importantly, there may be also other unmeasured cantonal/regional characteristics associated with stage at presentation and/or survival that could impact the results. Therefore, we additionally adjusted for canton of residence in the final models. Generalizability of these finding, although better than previous publications, remains limited by the lack of cantonal CR participation and should be made with caution.
Another weakness of the study is the lack of more detailed tumor characteristics [(morphologic subtype, grade, oestrogen receptor (ER) status, progesterone-receptor status], human epidermal growth factor receptor 2 (HER2/neu) and other prognostic factors such as comorbidities and cancer treatment. From studies outside of Switzerland, it is known that morphological type of BC and ER status might vary between social groups. 13 A Swiss study conducted in Geneva reported variations depending on SEP for stage at presentation and morphological BC type, but not for grade, tumor size and ER status. 14 Substantial treatment differences between social groups have been also been reported for this canton. 14, 15 Additional analysis of morphological type by SEP (not presented) suggests that morphological differences reported from Geneva might be largely the result of varying proportions of cases with unknown morphological type (classified as other morphological type in their analyzes) rather than reflecting real morphological differences between social groups. Further, stage at presentation has been consistently shown to be a major predictor of BC survival and other tumor characteristics contributed much less to the explanation of the observed survival experience. 13 Comorbidities are more common in lower SEP women and may have an adverse impact on cancer survival. 35 Comorbidities might be associated with less complete diagnostic assessment including biopsy for staging, 32, 33 limited treatment options and a decreased likelihood to receive treatment with curative intent. 47 Further, SEP might influence patients treatment choice 48 and/or adherence to treatment. 49 However, studies in the canton of Geneva suggest that observed survival inequalities after BC are-at least partlycaused by differences in care management depending on SEP. 14, 15 Unfortunately, information on comorbidities were not available for this study.
Since the introduction of BC screening programs, the usefulness of mammography screening has been questioned. Critics argue that screening-induced over-diagnosis and its consequences outbalance potential mortality benefits. 50 Consequently, our analyzes might be affected by higher proportions of over-diagnosis in the cantons with implemented screening program resulting in higher mammography screening coverage. Finally, we used the SEER basic summary staging because substantial TNM classification changes over the investigated time period prevented the use of the more detailed TNMstaging. A more detailed staging system might have shown stronger effects.
Conclusions
Characteristics associated with later stage BC diagnosis in Switzerland were lower SEP, being unmarried, being outside of the recommended screening age and living in a canton without an organized BC screening program. In addition, women of lower SEP experienced poorer disease-specific survival. Notably, these survival inequalities could not be explained by socioeconomic differences at stage of presentation and/or other sociodemographic factors such as age, nationality and civil status. Appropriate intervention strategies are needed to reduce socioeconomic and demographic health inequalities in women with BC.
